Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, Sillano F, Buttarelli M, Piermattei A, Loverro M, Camarda F, Greco V, De Bonis M, Minucci A, Gallo D, Urbani A, Vizzielli G, Scambia G, Sette C.
Cesari E, et al. Among authors: caggiano c.
J Exp Clin Cancer Res. 2023 May 18;42(1):126. doi: 10.1186/s13046-023-02682-5.
J Exp Clin Cancer Res. 2023.
PMID: 37202753
Free PMC article.